Changes in support for smoke-free policy among smokers in six European countries
More details
Hide details
Catalan Institute of Oncology (ICO), Spain
Biomedical Research Institute (IDIBELL), Spain
Universitat de Barcelona (UB), Spain
Publish date: 2019-03-26
Tob. Prev. Cessation 2019;5(Supplement):A137
Download abstract book (PDF)

This paper aims to examine changes in the smokers’ support for bans in different settings, and explore the determinants of changes in smokers’ opinions about smoking in different settings in six European countries.

Longitudinal survey (the ITC 6 European Country Survey, part of the EUREST-PLUS Project) using nationally representative samples of adult smokers in Germany, Greece, Hungary, Poland, Romania and Spain. Data were collected in 2016 (wave 1) and 2018 (wave 2). Generalized estimating equation logistic regression models were used to estimate the support in each wave and then test the change in adjusted percentages between waves.

In the six countries there was an overall significant increase in support for smoking bans in nine out of eleven settings. Policies that protect children and teenagers against smoke continued to be the most supported in wave 2 (>90%). Smokers in Greece were outliers in comparison to other countries with a decrease in their support in nine out of eleven policies surveyed. In contrast, smokers in Hungary and Spain had an increase in their support in all policies. Smokers belonging to the younger age group had the biggest increase in support for smoking bans. Those who quitted between waves consistently had higher support for smoking bans compared to daily smokers.

The support for smoke-free regulations increased among European smokers. Specific groups of smokers should be studied to determine why they are still resistant to support smoke-free regulations and how to tailor interventions to inform them about the benefits of such regulations.

The EUREST-PLUS Project takes place with the financial support of the European Commission, Horizon 2020 HCO-6-2015 programme (EUREST-PLUS: 681109; CV) and the University of Waterloo (GTF). Additional support was provided to the University of Waterloo by the Canadian Institutes of Health Research (FDN-148477). EF was supported by the Ministry of Research and Universities from the Government of Catalonia (2017SGR319).